HDAC9 and hepatocellular carcinoma: HDAC inhibitors are being developed for the treatment of HCC, which reactivate the expression of tumor suppressor genes, induce apoptosis and differentiation, and also inhibit tumor growth, angiogenesis, and metastasis (151).